151 related articles for article (PubMed ID: 9539662)
41. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
42. Effects of various absorption enhancers on transport of clodronate through Caco-2 cells.
Raiman J; Törmälehto S; Yritys K; Junginger HE; Mönkkönen J
Int J Pharm; 2003 Aug; 261(1-2):129-36. PubMed ID: 12878401
[TBL] [Abstract][Full Text] [Related]
43. Ex vivo and in vivo diffusion of ropivacaine through spinal meninges: influence of absorption enhancers.
Brandhonneur N; Dollo G; Ratajczak-Enselme M; Deniau AL; Chevanne F; Estèbe JP; Legrand A; Le Corre P
Int J Pharm; 2011 Feb; 404(1-2):36-41. PubMed ID: 21056096
[TBL] [Abstract][Full Text] [Related]
44. In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.
Cox AB; Rawlinson LA; Baird AW; Bzik V; Brayden DJ
Pharm Res; 2008 Jan; 25(1):114-22. PubMed ID: 17546408
[TBL] [Abstract][Full Text] [Related]
45. Dodecylphosphocholine-mediated enhancement of paracellular permeability and cytotoxicity in Caco-2 cell monolayers.
Liu DZ; LeCluyse EL; Thakker DR
J Pharm Sci; 1999 Nov; 88(11):1161-8. PubMed ID: 10564065
[TBL] [Abstract][Full Text] [Related]
46. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans.
Lennernäs H; Gjellan K; Hallgren R; Graffner C
J Pharm Pharmacol; 2002 Apr; 54(4):499-508. PubMed ID: 11999127
[TBL] [Abstract][Full Text] [Related]
47. Oral treatment with plecanatide or dolcanatide attenuates visceral hypersensitivity
Boulete IM; Thadi A; Beaufrand C; Patwa V; Joshi A; Foss JA; Eddy EP; Eutamene H; Palejwala VA; Theodorou V; Shailubhai K
World J Gastroenterol; 2018 May; 24(17):1888-1900. PubMed ID: 29740204
[TBL] [Abstract][Full Text] [Related]
48. Difructose anhydride III and sodium caprate activate paracellular transport via different intracellular events in Caco-2 cells.
Suzuki T; Hara H
Life Sci; 2006 Jun; 79(4):401-10. PubMed ID: 16566947
[TBL] [Abstract][Full Text] [Related]
49. In vitro and in vivo evaluation of effects of sodium caprate on enteral peptide absorption and on mucosal morphology.
Chao AC; Nguyen JV; Broughall M; Griffin A; Fix JA; Daddona PE
Int J Pharm; 1999 Nov; 191(1):15-24. PubMed ID: 10556736
[TBL] [Abstract][Full Text] [Related]
50. In vitro and in vivo evaluation of the enhancing activity of glycyrrhizin on the intestinal absorption of drugs.
Imai T; Sakai M; Ohtake H; Azuma H; Otagiri M
Pharm Res; 1999 Jan; 16(1):80-6. PubMed ID: 9950283
[TBL] [Abstract][Full Text] [Related]
51. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers.
Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A
Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126
[TBL] [Abstract][Full Text] [Related]
52. Effects of sodium deoxycholate and sodium caprate on the transport of epirubicin in human intestinal epithelial Caco-2 cell layers and everted gut sacs of rats.
Lo YL; Huang JD
Biochem Pharmacol; 2000 Mar; 59(6):665-72. PubMed ID: 10677583
[TBL] [Abstract][Full Text] [Related]
53. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
54. Enhanced bioavailability of cefoxitin using palmitoyl L-carnitine. I. Enhancer activity in different intestinal regions.
Sutton SC; LeCluyse EL; Cammack L; Fix JA
Pharm Res; 1992 Feb; 9(2):191-4. PubMed ID: 1553340
[TBL] [Abstract][Full Text] [Related]
55. Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models.
Zornoza T; Cano-Cebrián MJ; Nalda-Molina R; Guerri C; Granero L; Polache A
Eur J Pharm Sci; 2004 Aug; 22(5):347-56. PubMed ID: 15265504
[TBL] [Abstract][Full Text] [Related]
56. Regulation of tight junction permeability by sodium caprate in human keratinocytes and reconstructed epidermis.
Kurasawa M; Kuroda S; Kida N; Murata M; Oba A; Yamamoto T; Sasaki H
Biochem Biophys Res Commun; 2009 Apr; 381(2):171-5. PubMed ID: 19338770
[TBL] [Abstract][Full Text] [Related]
57. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
Lv XY; Li J; Zhang M; Wang CM; Fan Z; Wang CY; Chen L
AAPS PharmSciTech; 2010 Mar; 11(1):372-82. PubMed ID: 20237966
[TBL] [Abstract][Full Text] [Related]
58. Effect of some amino acids on the rectal irritation caused by sodium caprate in conscious rats.
Kinouchi Y; Yata N
Biol Pharm Bull; 1996 Mar; 19(3):375-8. PubMed ID: 8924904
[TBL] [Abstract][Full Text] [Related]
59.
Tran H; Aihara E; Mohammed FA; Qu H; Riley A; Su Y; Lai X; Huang S; Aburub A; Chen JJH; Vitale OH; Lao Y; Estwick S; Qi Z; ElSayed MEH
Mol Pharm; 2023 Feb; 20(2):929-941. PubMed ID: 36592951
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of intestinal absorption and mucosal toxicity using two promoters. II. Rat instillation and perfusion studies.
Maher S; Wang X; Bzik V; McClean S; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):301-11. PubMed ID: 19664704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
